Before, during, or after your injection—no matter when you have questions, we’re available to help you manage your RMS therapy with helpful tips and tools.

Preparation tips for injecting Teva's COPAXONE®:

Set up a free, in-home, 1-on-1 injection training. Even if you have used an injectable therapy before, you should be trained by a doctor or nurse before you inject COPAXONE® for the first time. To schedule training at any time throughout your therapy experience, call Teva’s Shared Solutions® at 1-800-887-8100 and ask to speak with one of our MS-certified nurses. Your session can be as short or as long as you need it to be.

Organize your supplies

Download our Injection Guide for easy-to-reference materials you can print out to use when injecting. Start by placing each item you'll need on a clean, flat surface1:

  • 1 COPAXONE® Pre-filled Syringe

  • The autoject®2 for glass syringe (if you're using it)

  • A warm compress (if you're using it)

  • An alcohol wipe

  • A dry cotton ball

  • A used-syringe disposal container

  • Always wash your hands before injecting.1

  • Remember—wait 20 minutes until your pre-filled syringe has reached room temperature before injecting.1

  • Some people find it helpful to use a warm compress before injecting.

  • Always use a cloth barrier between bare skin and the warm compress.

  • Do not use the warm compress in areas where sensation of temperature is impaired.

  • Alternatively, it may help to ice the site for 1 minute before cleaning the site and injecting.

  • Clean your injection site with an alcohol wipe, and make sure your skin is dry before injecting.1

  • Rotation matters. It is extremely important to rotate your injection areas (and sites within each area) to help keep your skin as healthy as possible.1

A diagram of three of seven injection sites to rotate for  COPAXONE® therapy. A diagram of the four of seven injection sites to rotate for  COPAXONE® therapy.

  • There are 7 injection areas to rotate between. Download the COPAXONE iTracker® 2.0 app to keep track of your injection areas, and be sure that you do not inject in the same place (site) more than 1 time each week.1

  • Your doctor may be able to recommend other appropriate injection sites, if needed. To make an appointment for a free, in-home, 1-on-1 injection training when you start COPAXONE® therapy and at any time throughout your therapy experience, call Teva’s Shared Solutions® at 1-800-887-8100.

  • Depth matters. If using the autoject®2 for glass syringe, different areas of your body may require different depth settings. Using depth settings that are too deep or too shallow may contribute to injection site reactions. Finding the right depth setting for each injection area can help make your injections more comfortable.

  • Avoid injecting into sites with birthmarks, tattoos, stretch marks and scars and/or other skin irregularities.

  • If there are particles in the syringe or the solution is cloudy, do not use it.1 Report this event to Teva’s Shared Solutions®.

  • Never inject with a needle that has been dropped on the floor or has come in contact with any other surface. Start over with a new syringe.

  • Avoid hot showers or baths after you inject.

  • Do not massage the site immediately after injecting—this can damage underlying tissue. Wait at least 24 hours after injecting.

  • Dispose of used syringes in a hard-walled plastic or disposable biohazard sharps container immediately after you inject.1

  • If you miss a dose, take your COPAXONE® as soon as you remember. If it is nearer to the time of your next scheduled dose, skip the missed dose and resume your usual dosing schedule.

  • If you have any questions about missing a dose, contact Teva’s Shared Solutions® at 1-800-887-8100 or your healthcare provider for assistance.

Please see full Prescribing Information.


COPAXONE® (glatiramer acetate injection) is prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis (MS).

Important Safety Information

Do not take COPAXONE® if you are allergic to glatiramer acetate or mannitol.

Some patients report a short-term reaction right after or within minutes after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain, fast heart beat, anxiety, and trouble breathing. These symptoms generally appear within seconds to minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again.

Chest pain may occur either as part of the immediate post-injection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense.

A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.

The most common side effects of COPAXONE® include redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE®. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE®.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

Please see full Prescribing Information for Teva's COPAXONE®.

Reference: 1. COPAXONE® (glatiramer acetate injection) Current Prescribing Information. Teva Neuroscience, Inc.

Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.

autoject®2 for glass syringe is a registered trademark of Owen Mumford, Ltd. Available by prescription only.
Apple is a registered trademark of Apple Inc. App Store is a service mark of Apple Inc.
Google Play and the Google Play logo are trademarks of Google LLC.

You are about to leave and enter a website operated by a third party.

Would you like to continue?

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?